Detalles de la búsqueda
1.
The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
Liver Transpl;
23(11): 1404-1414, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28590598
2.
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
J Gastroenterol Hepatol;
28(1): 153-60, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22989351
3.
Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Lancet Oncol;
13(2): 196-206, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22173060
4.
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Cancer;
118(19): 4715-24, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22392525
5.
Transforming growth factor ß1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
Liver Transpl;
17(3): 279-88, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21384510
6.
Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Liver Transpl;
17(3): 289-98, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21384511
7.
Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma.
Liver Int;
31(7): 1006-12, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21733090
8.
Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra) in liver transplantation: an open, prospective, single-arm phase III study.
Transpl Int;
24(5): 441-50, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21294780
9.
IL-6 and IL-10 in post-transplant lymphoproliferative disorders development and maintenance: a longitudinal study of cytokine plasma levels and T-cell subsets in 38 patients undergoing treatment.
Transpl Int;
24(9): 892-903, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21668529
10.
BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients.
Eur J Haematol;
84(1): 26-33, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19799626
11.
Successful endoscopic and surgical management of non-anastomotic biliary strictures after liver transplantation - case report.
Ann Transplant;
14(1): 47-51, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19289996
12.
Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy).
Transplantation;
83(3): 351-3, 2007 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17297412
13.
Influence of donor histology on outcome in patients undergoing transplantation for hepatitis C.
Transplantation;
84(2): 144-8, 2007 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-17667804
14.
Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
Transplantation;
84(3): 387-91, 2007 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17700165
15.
Influence of basiliximab induction therapy on long term outcome after liver transplantation, a prospectively randomised trial.
Ann Transplant;
12(3): 15-21, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18290565
16.
Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
Ann Transplant;
12(3): 22-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18290566
17.
Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin.
Transplantation;
82(1): 43-7, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16861940
18.
Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy.
Hepat Res Treat;
2016: 8325467, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27195149
19.
Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantation.
Head Neck;
38(5): 707-14, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25521431
20.
Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth.
World J Gastroenterol;
11(10): 1420-5, 2005 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-15770715